Aetna Company Profile (NYSE:AET)

About Aetna (NYSE:AET)

Aetna logoAetna Inc. is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers' compensation administrative services and health information technology (HIT) products and services. The Health Care segment consists of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an Insured basis and an employer-funded basis, and emerging businesses products and services. The Group Insurance segment includes group life insurance and group disability products. Its products are offered on an Insured basis.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Managed Health Care
  • Sub-Industry: Managed Health Care
  • Symbol: NYSE:AET
  • CUSIP: 00817Y10
  • Web:
  • Market Cap: $53.96096 billion
  • Outstanding Shares: 332,100,000
Average Prices:
  • 50 Day Moving Avg: $157.45
  • 200 Day Moving Avg: $145.52
  • 52 Week Range: $104.59 - $164.52
  • Trailing P/E Ratio: 35.74
  • Foreward P/E Ratio: 15.89
  • P/E Growth: 1.81
Sales & Book Value:
  • Annual Revenue: $62.2 billion
  • Price / Sales: 0.86
  • Book Value: $46.38 per share
  • Price / Book: 3.47
  • Annual Dividend: $2.00
  • Dividend Yield: 1.2%
  • EBIDTA: $6.06 billion
  • Net Margins: 2.52%
  • Return on Equity: 20.52%
  • Return on Assets: 5.35%
  • Debt-to-Equity Ratio: 0.46%
  • Current Ratio: 0.48%
  • Quick Ratio: 0.48%
  • Average Volume: 1.80 million shs.
  • Beta: 0.53
  • Short Ratio: 3.37

Frequently Asked Questions for Aetna (NYSE:AET)

What is Aetna's stock symbol?

Aetna trades on the New York Stock Exchange (NYSE) under the ticker symbol "AET."

How often does Aetna pay dividends? What is the dividend yield for Aetna?

Aetna declared a quarterly dividend on Friday, May 19th. Stockholders of record on Thursday, July 13th will be given a dividend of $0.50 per share on Friday, July 28th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.24%. The ex-dividend date is Tuesday, July 11th. View Aetna's Dividend History.

How will Aetna's stock buyback program work?

Aetna announced that its Board of Directors has initiated a stock repurchase plan on Friday, April 7th 2017, which authorizes the company to repurchase $4,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 98% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's leadership believes its shares are undervalued.

How were Aetna's earnings last quarter?

Aetna Inc. (NYSE:AET) released its quarterly earnings results on Thursday, August, 3rd. The company reported $3.42 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $2.34 by $1.08. The company earned $15.52 billion during the quarter, compared to analysts' expectations of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The business's revenue for the quarter was down 2.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.21 earnings per share. View Aetna's Earnings History.

When will Aetna make its next earnings announcement?

Aetna is scheduled to release their next quarterly earnings announcement on Thursday, October, 26th 2017. View Earnings Estimates for Aetna.

What guidance has Aetna issued on next quarter's earnings?

Aetna issued an update on its FY17 earnings guidance on Thursday, August, 3rd. The company provided earnings per share (EPS) guidance of $9.45-9.55 for the period, compared to the Thomson Reuters consensus estimate of $8.99.

Where is Aetna's stock going? Where will Aetna's stock price be in 2017?

19 equities research analysts have issued 1-year price targets for Aetna's stock. Their predictions range from $128.00 to $185.00. On average, they anticipate Aetna's stock price to reach $160.63 in the next year. View Analyst Ratings for Aetna.

What are analysts saying about Aetna stock?

Here are some recent quotes from research analysts about Aetna stock:

  • 1. According to Zacks Investment Research, "Aetna expects long-term growth from its Government business. Cost-reduction initiatives, growing ACO collaborations pave the way for long-term growth. A strong balance sheet is another positive. Following a strong first quarter results, Aetna increased its earnings guidance. Year to date, the stock of Aetna has outperformed the Zacks categorized Medical Health Maintenance Organization industry. The stock has also witnessed an upward revision in earning estimates over the past 60 days. However, Aetna’s merger with Humana, which would have raised its rank in the industry, has been called off. Aetna has also been incurring losses in its public exchange business and has been exiting exchanges to avoid losses from this business. Furthermore, its membership growth remains under pressure. Increasing medical benefit ratios are also likely to hurt margins." (7/4/2017)
  • 2. Cantor Fitzgerald analysts commented, "There is life after Humana. CEO Mark Bertolini opened the meeting discussing life after Humana. With a continued focus to grow its government business, Mr. Bertolini indicated that Humana represented a means to an end." Instead, AET will now chose to build its government business organically. We believe the company will also pursue acquisitions to build out its capabilities in specific geographies. CFO Shawn Guertin identified Medicare as a great growth opportunity, but characterized Medicaid as a good opportunity. Growth in Medicaid slowed recently due to two contract losses and potential for structural changes to Medicaid exist." (5/12/2017)
  • 3. Royal Bank Of Canada analysts commented, "After the close on Monday, April 24, Humana pre-released 1Q17 EPS ahead of its investor meeting, which will be held on Tuesday, April 25. 1Q17 Adjusted EPS for the quarter was $2.75 vs. our estimate of $2.50 and FactSet consensus of $2.49." (4/24/2017)
  • 4. Oppenheimer Holdings, Inc. analysts commented, "Overall, we believe Humana is well positioned for growth, given the political support in Washington, ample strategic capital to deploy and the potential for upside to its current earnings base."Ultimately, this will also remain a desirable asset that could be acquired by another insurer." (3/31/2017)
  • 5. Jefferies Group LLC analysts commented, "AET's 4Q EPS was strong (beat by 13%), while initial 2017 guidance was below consensus on both the top and bottom line. As always, favorable prior period development (PPD) is excluded from the outlook and could generate upside. Looking to 2018, earnings growth should accelerate from buyback tailwinds and exiting HIX. We bump up our EPS projections for capital deployment, but remain Hold as the stock seems fairly valued." (2/1/2017)

Who are some of Aetna's key competitors?

Who are Aetna's key executives?

Aetna's management team includes the folowing people:

  • Mark T. Bertolini, Chairman of the Board, Chief Executive Officer
  • Karen S. Lynch, President
  • Shawn M. Guertin, Chief Financial Officer, Executive Vice President, Chief Enterprise Risk Officer
  • Thomas J. Sabatino Jr., Executive Vice President, General Counsel
  • Gary W. Loveman Ph.D., Executive Vice President - Consumer and Health Services
  • Margaret M. McCarthy, Executive Vice President - Operations and Technology
  • Harold L. Paz M.D., Executive Vice President, Chief Medical Officer
  • Francis S. Soistman Jr., Executive Vice President - Government Services
  • Edward J. Ludwig, Lead Independent Director
  • Fernando G. Aguirre, Independent Director

Who owns Aetna stock?

Aetna's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.81%), Vanguard Group Inc. (6.70%), Capital World Investors (6.25%), State Street Corp (6.22%), FMR LLC (4.14%) and Alliancebernstein L.P. (1.53%). Company insiders that own Aetna stock include Francis S Soistman Jr, Gary W Loveman, Jeffrey E Garten, Margaret M Mccarthy, Mark T Bertolini, Molly Joel Coye and Shawn M Guertin. View Institutional Ownership Trends for Aetna.

Who sold Aetna stock? Who is selling Aetna stock?

Aetna's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Glenview Capital Management LLC, BlackRock Inc., Orbis Allan Gray Ltd, State Street Corp, Maverick Capital Ltd., Vanguard Group Inc. and HealthCor Management L.P.. Company insiders that have sold Aetna stock in the last year include Francis S Soistman Jr, Margaret M Mccarthy, Mark T Bertolini and Shawn M Guertin. View Insider Buying and Selling for Aetna.

Who bought Aetna stock? Who is buying Aetna stock?

Aetna's stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Janus Henderson Group PLC, Capital World Investors, Samlyn Capital LLC, Harbour Capital Advisors LLC, Parametric Portfolio Associates LLC, Marshall Wace North America L.P. and Fred Alger Management Inc.. View Insider Buying and Selling for Aetna.

How do I buy Aetna stock?

Shares of Aetna can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aetna's stock price today?

One share of Aetna stock can currently be purchased for approximately $161.00.

MarketBeat Community Rating for Aetna (NYSE AET)
Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  647 (Vote Outperform)
Underperform Votes:  395 (Vote Underperform)
Total Votes:  1,042
MarketBeat's community ratings are surveys of what our community members think about Aetna and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Aetna (NYSE:AET) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 5 Hold Ratings, 14 Buy Ratings
Consensus Rating:Buy (Score: 2.74)
Consensus Price Target: $160.63 (0.23% downside)

Analysts' Ratings History for Aetna (NYSE:AET)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/12/2017ArgusReiterated RatingBuy$165.00 -> $185.00LowView Rating Details
8/17/2017Morgan StanleyBoost Price TargetOverweight$172.00 -> $179.00LowView Rating Details
8/9/2017Cantor FitzgeraldReiterated RatingOverweight$150.00 -> $175.00LowView Rating Details
8/7/2017Deutsche Bank AGBoost Price TargetHold$157.00 -> $163.00LowView Rating Details
8/4/2017Jefferies Group LLCReiterated RatingHold$157.00 -> $163.00LowView Rating Details
8/4/2017Royal Bank Of CanadaBoost Price TargetOutperform -> Outperform$162.00 -> $171.00MediumView Rating Details
7/13/2017Credit Suisse GroupReiterated RatingOutperform$160.00 -> $165.00LowView Rating Details
6/28/2017Citigroup Inc.Initiated CoverageBuy -> Buy$180.00LowView Rating Details
5/27/2017Cowen and CompanySet Price TargetBuy$145.00 -> $170.00N/AView Rating Details
5/17/2017Bank of America CorporationReiterated RatingBuy$160.00 -> $168.00MediumView Rating Details
5/16/2017Stifel NicolausBoost Price TargetBuy -> Buy$150.00 -> $158.00LowView Rating Details
5/15/2017Barclays PLCReiterated RatingOverweight$162.00LowView Rating Details
5/11/2017Cleveland ResearchUpgradeNeutral -> BuyLowView Rating Details
4/3/2017CIBCReiterated RatingOutperformLowView Rating Details
3/31/2017Oppenheimer Holdings, Inc.Reiterated RatingOutperformLowView Rating Details
1/31/2017Sanford C. BernsteinDowngradeOutperform -> Market PerformN/AView Rating Details
1/24/2017Leerink SwannDowngradeOutperform -> Market Perform$135.00N/AView Rating Details
1/4/2017Piper Jaffray CompaniesInitiated CoverageNeutral$136.00N/AView Rating Details
9/22/2016Evercore ISIInitiated CoverageBuy$128.00N/AView Rating Details
8/17/2016FBR & CoReiterated RatingHoldN/AView Rating Details
7/21/2016Wolfe ResearchDowngradeOutperform -> Peer PerformN/AView Rating Details
6/2/2016Wells Fargo & CompanyReiterated RatingBuyN/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
2/3/2016BMO Capital MarketsBoost Price TargetOutperform$128.00 -> $129.00N/AView Rating Details
2/2/2016WedbushLower Price TargetNeutral$130.00 -> $120.00N/AView Rating Details
10/30/2015J P Morgan Chase & CoLower Price Target$144.00 -> $141.00N/AView Rating Details
(Data available from 9/19/2015 forward)


Earnings History for Aetna (NYSE:AET)
Earnings by Quarter for Aetna (NYSE:AET)
Earnings History by Quarter for Aetna (NYSE AET)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/31/2017$2.07N/AView Earnings Details
8/3/2017Q2 2017$2.34$3.42$15.34 billion$15.52 billionViewListenView Earnings Details
5/2/2017Q1 2017$2.36$2.71$15.39 billion$15.17 billionViewListenView Earnings Details
1/31/2017Q416$1.44$1.63$15.84 billion$15.73 billionViewListenView Earnings Details
10/27/2016Q316$2.02$2.07$15.71 billion$15.78 billionViewListenView Earnings Details
8/2/2016Q216$2.12$2.21$15.69 billion$15.95 billionViewListenView Earnings Details
4/28/2016Q116$2.23$2.30$15.46 billion$15.69 billionViewListenView Earnings Details
2/1/2016Q415$1.21$1.37$14.93 billion$15.09 billionViewListenView Earnings Details
10/29/2015Q315$1.77$1.90$15.22 billion$15.00 billionViewListenView Earnings Details
8/4/2015Q215$1.82$2.05$15.43 billion$15.13 billionViewListenView Earnings Details
4/28/2015Q115$1.96$2.39$15.48 billion$15.09 billionViewListenView Earnings Details
2/3/2015Q414$1.22$1.22$14.59 million$14.77 millionViewListenView Earnings Details
10/28/2014Q214$1.58$1.79$14.63 billion$14.70 billionViewListenView Earnings Details
7/29/2014Q114$1.61$1.69$13.98 billion$14.50 billionViewListenView Earnings Details
4/24/2014Q413$1.56$1.98$13.69 billion$13.97 billionViewListenView Earnings Details
2/6/2014Q313$1.36$1.34$13.14 billion$13.13 billionViewListenView Earnings Details
10/29/2013Q213$1.53$1.53$12.89 billion$12.99 billionViewListenView Earnings Details
7/30/2013Q2 2013$1.39$1.52$12.02 billion$11.56 billionViewListenView Earnings Details
4/30/2013Q1 2013$1.38$1.50$9.65 billion$9.51 billionViewListenView Earnings Details
1/31/2013Q4 2012$0.96$0.94$8.97 billion$8.96 billionViewListenView Earnings Details
10/25/2012Q312$1.34$1.55$8.96 billion$8.90 billionViewN/AView Earnings Details
7/31/2012$1.25$1.31ViewN/AView Earnings Details
4/26/2012$1.39$1.34ViewN/AView Earnings Details
2/1/2012$0.96$0.97ViewN/AView Earnings Details
10/27/2011$1.14$1.40ViewN/AView Earnings Details
7/27/2011$1.07$1.35ViewN/AView Earnings Details
4/28/2011$0.97$1.43ViewN/AView Earnings Details
2/4/2011$0.62$0.63ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Aetna (NYSE:AET)
2017 EPS Consensus Estimate: $8.34
2018 EPS Consensus Estimate: $10.02
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$2.29$2.40$2.33
Q2 20174$2.30$2.38$2.35
Q3 20174$2.08$2.42$2.17
Q4 20174$1.26$1.74$1.49
Q1 20181$2.76$2.76$2.76
Q2 20181$2.72$2.72$2.72
Q3 20181$2.70$2.70$2.70
Q4 20181$1.84$1.84$1.84
(Data provided by Zacks Investment Research)


Current Dividend Information for Aetna (NYSE:AET)
Most Recent Dividend:7/28/2017
Annual Dividend:$2.00
Dividend Yield:1.24%
Dividend Growth:7.70% (3 Year Average)
Payout Ratio:43.67% (Trailing 12 Months of Earnings)
21.01% (Based on This Year's Estimates)
19.74% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Aetna (NYSE:AET)

Dividend History by Quarter for Aetna (NYSE AET)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Aetna (NYSE:AET)
Insider Ownership Percentage: 1.14%
Institutional Ownership Percentage: 89.52%
Insider Trades by Quarter for Aetna (NYSE:AET)
Institutional Ownership by Quarter for Aetna (NYSE:AET)
Insider Trades by Quarter for Aetna (NYSE:AET)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/7/2017Margaret M MccarthyEVPSell27,028$149.23$4,033,388.44View SEC Filing  
5/17/2017Mark T BertoliniChairmanSell103,547$140.79$14,578,382.13View SEC Filing  
3/23/2017Shawn M GuertinInsiderSell29,602$129.35$3,829,018.70View SEC Filing  
3/8/2017Francis S Soistman JrVPSell6,607$131.98$871,991.86View SEC Filing  
9/7/2016Jeffrey E. GartenDirectorSell7,100$116.51$827,221.00View SEC Filing  
8/23/2016Shawn M GuertinInsiderSell45,328$120.21$5,448,878.88View SEC Filing  
5/10/2016Margaret M MccarthyEVPSell39,169$114.45$4,482,892.05View SEC Filing  
5/3/2016Mark T BertoliniCEOSell33,510$114.00$3,820,140.00View SEC Filing  
3/15/2016Gary W LovemanEVPBuy8,970$111.45$999,706.50View SEC Filing  
2/22/2016Molly Joel CoyeDirectorSell1,175$106.28$124,879.00View SEC Filing  
12/23/2015Margaret M MccarthyEVPSell18,373$109.97$2,020,478.81View SEC Filing  
12/22/2015Mark T. BertoliniCEOSell26,996$110.00$2,969,560.00View SEC Filing  
8/14/2015Joseph M ZubretskyEVPSell179,087$118.66$21,250,463.42View SEC Filing  
8/13/2015Franklin Barbara HackmanDirectorSell2,064$118.47$244,522.08View SEC Filing  
3/31/2015Joseph M ZubretskyEVPSell200,000$107.96$21,592,000.00View SEC Filing  
3/27/2015Joseph M ZubretskyEVPSell86,958$107.24$9,325,375.92View SEC Filing  
3/26/2015Joseph M ZubretskyInsiderSell162,066$106.98$17,337,820.68View SEC Filing  
3/26/2015Margaret M MccarthyEVPSell27,670$106.04$2,934,126.80View SEC Filing  
3/25/2015Franklin Barbara HackmanDirectorSell3,000$108.75$326,250.00View SEC Filing  
3/17/2015William James CasazzaVPSell14,000$105.07$1,470,980.00View SEC Filing  
3/2/2015Molly Joel CoyeDirectorSell2,500$100.27$250,675.00View SEC Filing  
2/10/2015Rajan ParmeswarVPSell5,300$95.60$506,680.00View SEC Filing  
6/16/2014Molly Joel CoyeDirectorSell1,650$80.60$132,990.00View SEC Filing  
6/12/2014William James CasazzaVPSell15,906$80.58$1,281,705.48View SEC Filing  
5/27/2014Franklin Barbara HackmanDirectorSell2,665$77.26$205,897.90View SEC Filing  
2/19/2014Rajan ParmeswarVPSell3,600$69.46$250,056.00View SEC Filing  
12/30/2013Mark BertoliniCEOSell130,272$68.08$8,868,917.76View SEC Filing  
12/27/2013William James CasazzaVPSell10,299$68.25$702,906.75View SEC Filing  
8/26/2013William James CasazzaVPSell15,745$64.66$1,018,071.70View SEC Filing  
6/18/2013William James CasazzaVPSell40,598$62.00$2,517,076.00View SEC Filing  
5/21/2013Molly Joel CoyeDirectorSell2,000$60.38$120,760.00View SEC Filing  
5/20/2013Joseph P NewhouseDirectorSell14,000$59.15$828,100.00View SEC Filing  
5/15/2013Rajan ParmeswarVPSell1,435$60.13$86,286.55View SEC Filing  
2/6/2013Karen RohanVPBuy4,035$49.53$199,853.55View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Aetna (NYSE:AET)
Latest Headlines for Aetna (NYSE:AET)
DateHeadline logo5 Reasons Why You Should Buy Aetna's (AET) Stock Right Now - Nasdaq - September 18 at 9:03 PM logo5 Reasons Why You Should Buy Aetna's (AET) Stock Right Now - September 18 at 4:00 PM logo5 Reasons Why You Should Buy Aetna's (AET) Stock Right Now - September 18 at 4:00 PM logoTake Two: Inside Bill Cassidy's Plan To Replace Obamacare - September 17 at 1:31 AM logo4 HMO Stocks Standing Out in a Top-Ranked Industry - September 15 at 3:52 PM logoCritical Survey: Aetna (AET) vs. Anthem (ANTM) - September 15 at 6:52 AM logoWhy the Earnings Streak Will Continue for Aetna Inc. (AET) - Nasdaq - September 14 at 3:30 PM logoWhy the Earnings Streak Will Continue for Aetna Inc. (AET) - September 14 at 3:30 PM logoWireless Carriers Eager to Connect Apple Watch Series 3 to Their Networks - September 13 at 1:53 AM logoWhy Aetna Inc (AET) Could Be A Buy - September 13 at 1:52 AM logoAetna Inc. (AET) Given Average Rating of "Buy" by Analysts - September 13 at 12:52 AM logoAlexion Pharmaceuticals is moving its headquarters to Boston - September 12 at 4:41 PM logo6 GARP Stocks That Should Grace Your Portfolio - September 12 at 3:45 PM logoAetna Inc. (AET) Rating Reiterated by Argus - September 12 at 9:32 AM logo$15.09 Billion in Sales Expected for Aetna Inc. (AET) This Quarter - September 12 at 5:04 AM logoHere's How Apple Could Surprise Us With an Improved Apple Watch - September 12 at 2:14 AM logoThe Zacks Analyst Blog Highlights: Home Depot, Aetna, Dickinson, Kellogg and FirstEnergy - September 11 at 4:09 PM logoZacks: Brokerages Expect Aetna Inc. (AET) to Announce $2.08 Earnings Per Share - September 10 at 4:06 PM logoNeedham tech firm PTC to relocate HQ to Boston’s Seaport District - September 8 at 3:51 PM logoAetna Offers Assistance to Members Affected by Hurricane Irma - September 8 at 3:51 PM logoETFs with exposure to Aetna, Inc. : September 7, 2017 - September 7 at 3:31 PM logoAnthem cuts back Obamacare coverage in Kentucky - Reuters - September 6 at 8:31 PM logoAetna Executive to Present at CEO Investor Forum 2.0 - September 6 at 8:31 PM logoAetna, Inc. :AET-US: Earnings Analysis: Q2, 2017 By the Numbers : September 6, 2017 - September 6 at 3:30 PM logoComparing Aetna (AET) and Magellan Health (MGLN) - September 6 at 8:38 AM logoAetna sends apology letter to HIV patients for exposing personal information in mailing - August 31 at 8:30 PM logoMolina Healthcare's Top Line Grows on Membership, Debts Hurt - August 31 at 3:28 PM featured highlights include Lantheus Holdings, Jazz Pharmaceuticals, Gray Television, Aetna and Uniti Group - August 31 at 3:28 PM logoAetna Executive to Present at Morgan Stanley Global Healthcare Conference - August 29 at 8:54 PM logoLawsuit accuses Aetna of revealing patients' HIV information - Reuters - August 29 at 3:52 PM logoSuit: Aetna violated law with envelope revealing HIV status - August 28 at 3:25 PM logoAetna Offers Assistance to Members Affected by Hurricane Harvey in Texas and Louisiana - August 28 at 2:15 AM logoAetna May Have Exposed The HIV Status Of Thousands Of Clients - August 26 at 3:13 AM logoAetna Accidentally Revealed Customers HIV Status - August 25 at 5:09 PM logoAetna Letters Publicly Revealed Patients' HIV Status - August 25 at 5:09 PM logoAetna Letters Publicly Revealed Patients' HIV Status - August 25 at 5:09 PM logoSome Aetna customers had their HIV status exposed in mailing - August 25 at 2:20 PM logoAetna Inc. (AET) Expected to Announce Quarterly Sales of $15.05 Billion - August 25 at 1:22 PM logoAetna Accidentally Reveals HIV Status of Clients in Mailing to 12,000 - August 25 at 1:36 AM logoIs Fitbit Inc (FIT) Stock a Buy on Recent Apple Inc. (AAPL) Watch News? - - August 24 at 3:33 PM logoLawyers: Aetna envelope window reveals patients' HIV status - August 24 at 3:33 PM logoLawyers: Aetna envelope window reveals patients' HIV status - August 24 at 12:00 PM logoNovember 17th Options Now Available For Aetna (AET) - August 23 at 8:37 PM logoAetna, Inc. – Value Analysis (NYSE:AET) : August 23, 2017 - August 23 at 8:37 PM logo Brokerages Expect Aetna Inc. (AET) Will Announce Earnings of $2.08 Per Share - August 23 at 4:24 AM logoHow Massachusetts tried to woo insurance giant Aetna to Boston, and still lost - Boston Business Journal - August 22 at 9:09 PM logoWhy Aetna (AET) Could Be a Top Value Stock Pick - Yahoo Finance - August 22 at 9:08 PM logoToday's Research Report Coverage on Health Care Plans Stocks -- Express Scripts, Health Insurance Innovations, Aetna, and Cigna - August 22 at 4:08 PM logoAetna, Inc. : AET-US: Dividend Analysis : July 13th, 2017 (record date) : By the numbers : August 22, 2017 - August 22 at 4:07 PM logoWhy Aetna (AET) Could Be a Top Value Stock Pick - Nasdaq - August 21 at 3:45 PM



Aetna (AET) Chart for Tuesday, September, 19, 2017

This page was last updated on 9/19/2017 by Staff